Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Clinical trial NCT03271255 · UNKNOWN

Trial details

NCT number: NCT03271255
Sponsor: Shenzhen People's Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms

Start date: 2018-05-23
Primary completion: 2022-09-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.